CD47 and thyroid cancer: However, another peptide, 4 N1 (RFYVVMWK), which is also derived from the CD47/IAP-binding domain and has a similar structure to the 4N1K peptide (KRFYVVMWKK), has been shown to inhibit apoptosis of human thyroid cancer cells [26].